Randomized phase II trial of erlotinib versus temozolomide or carmustine in recurrent glioblastoma: EORTC brain tumor group study 26034. (Q33407127)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19204207 AND SRC:MED&resulttype=core&format=json

21 January 2020

title

Randomized phase II trial of erlotinib versus temozolomide or carmustine in recurrent glioblastoma: EORTC brain tumor group study 26034 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19204207 AND SRC:MED&resulttype=core&format=json

21 January 2020

main subject

phase II clinical trial

0 references

0 references

1 reference

1 reference

Martin J van den Bent

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19204207 AND SRC:MED&resulttype=core&format=json

21 January 2020

Alba A. Brandes

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19204207 AND SRC:MED&resulttype=core&format=json

21 January 2020

Mathilde Kouwenhoven

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19204207 AND SRC:MED&resulttype=core&format=json

21 January 2020

12

Martin J B Taphoorn

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19204207 AND SRC:MED&resulttype=core&format=json

21 January 2020

16

Denis Lacombe

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19204207 AND SRC:MED&resulttype=core&format=json

21 January 2020

17

Thierry Gorlia

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19204207 AND SRC:MED&resulttype=core&format=json

21 January 2020

8

Marc Frenay

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19204207 AND SRC:MED&resulttype=core&format=json

21 January 2020

5

Johan M Kros

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19204207 AND SRC:MED&resulttype=core&format=json

21 January 2020

author name string

Roy Rampling

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19204207 AND SRC:MED&resulttype=core&format=json

21 January 2020

Antoine F Carpentier

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19204207 AND SRC:MED&resulttype=core&format=json

21 January 2020

Paul M Clement

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19204207 AND SRC:MED&resulttype=core&format=json

21 January 2020

Mario Campone

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19204207 AND SRC:MED&resulttype=core&format=json

21 January 2020

Jean-Francois Baurain

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19204207 AND SRC:MED&resulttype=core&format=json

21 January 2020

Jean-Paul Armand

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19204207 AND SRC:MED&resulttype=core&format=json

21 January 2020

Alicia Tosoni

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19204207 AND SRC:MED&resulttype=core&format=json

21 January 2020

Heidemarie Kletzl

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19204207 AND SRC:MED&resulttype=core&format=json

21 January 2020

Barbara Klughammer

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19204207 AND SRC:MED&resulttype=core&format=json

21 January 2020

language of work or name

English

0 references

publication date

9 February 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19204207 AND SRC:MED&resulttype=core&format=json

Journal of Clinical Oncology

21 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19204207 AND SRC:MED&resulttype=core&format=json

21 January 2020

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19204207 AND SRC:MED&resulttype=core&format=json

21 January 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19204207 AND SRC:MED&resulttype=core&format=json

21 January 2020

page(s)

1268-1274

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19204207 AND SRC:MED&resulttype=core&format=json

Effect of food on the pharmacokinetics of erlotinib, an orally active epidermal growth factor receptor tyrosine-kinase inhibitor, in healthy individuals

21 January 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2667826

Coactivation of receptor tyrosine kinases affects the response of tumor cells to targeted therapies

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2667826

Epidermal growth factor receptor mutations in lung cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2667826

Rash as a surrogate marker for efficacy of epidermal growth factor receptor inhibitors in lung cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2667826

1p/19q loss within oligodendroglioma is predictive for response to first line temozolomide but not to salvage treatment.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2667826

Phase 1 study of erlotinib HCl alone and combined with temozolomide in patients with stable or recurrent malignant glioma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2667826

Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2667826

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2667826

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2667826

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2667826

Analysis of genomic rearrangements associated with EGRFvIII expression suggests involvement of Alu repeat elements

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2667826

Prognostic and predictive factors in breast cancer by immunohistochemical analysis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2667826

Sequential Treatment Assignment with Balancing for Prognostic Factors in the Controlled Clinical Trial

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2667826

Prognostic associations of activated mitogen-activated protein kinase and Akt pathways in glioblastoma.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2667826

Molecular study of malignant gliomas treated with epidermal growth factor receptor inhibitors: tissue analysis from North American Brain Tumor Consortium Trials 01-03 and 00-01.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2667826

Epidermal growth factor receptor, protein kinase B/Akt, and glioma response to erlotinib

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2667826

EGFR tyrosine kinase domain mutations in human gliomas

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2667826

How effective is BCNU in recurrent glioblastoma in the modern era? A phase II trial

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2667826

Phase II trial of gefitinib in recurrent glioblastoma

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2667826

Analysis of the phosphatidylinositol 3'-kinase signaling pathway in glioblastoma patients in vivo

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2667826

Diversity and frequency of epidermal growth factor receptor mutations in human glioblastomas.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2667826

Response criteria for phase II studies of supratentorial malignant glioma

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2667826

31 October 2018

Identifiers

DOI

10.1200/JCO.2008.17.5984

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19204207 AND SRC:MED&resulttype=core&format=json

21 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19204207 AND SRC:MED&resulttype=core&format=json

21 January 2020

PubMed publication ID

19204207

1 reference